<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03533855</url>
  </required_header>
  <id_info>
    <org_study_id>3D CP IRM</org_study_id>
    <nct_id>NCT03533855</nct_id>
  </id_info>
  <brief_title>Quality of Image and Performance Diagnoses of the 3D Sequence of Cholangio-pancreatography MRI in Apnea With Compressed Acquisition</brief_title>
  <official_title>Quality of Image and Performance Diagnoses of the 3D Sequence of Cholangio-pancreatography MRI in Apnea With Compressed Acquisition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe Hospitalier Paris Saint Joseph</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Groupe Hospitalier Paris Saint Joseph</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The sequence of 3D CP-IRM, used in current practice in the protocols of bilio-pancreatic&#xD;
      imaging, can be thus optimized to reduce acquisition time, thus the artefacts of movement, in&#xD;
      particular in 3T. It remains however to estimate if the quality of obtained image is&#xD;
      equivalent at least to that of the conventional sequence, without apnea, 3D CP-IRM.&#xD;
&#xD;
      To summarize, the investigators suggest comparing the classic sequence (Fast Relaxation Fast&#xD;
      Spin Echo (FRFSE) 3D) already existing with the same sequence to which will be added a&#xD;
      technique of CS allowing its acquisition at shortened time(weather), with respiratory trigger&#xD;
      on one hand and in apnea on the other hand. For the patient, this study will have for&#xD;
      consequence only the addition of 2 sequence MRI, one of the 2 minutes 30 seconds (with&#xD;
      respiratory trigger) and other one of the 20 seconds (in apnea).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 3, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Actual">April 25, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>image quality scale</measure>
    <time_frame>Day 1</time_frame>
    <description>Two senior radiologists will analyse the images of MRI with CS sequence</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Cholangiopancreatography</condition>
  <arm_group>
    <arm_group_label>&quot;CS plus FRFSE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>we perform a classic Fast Relaxation Fast Spin Echo (FRFSE) 3D MRI and add compressed sensing&quot; sequence</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>CS plus FRFSE</intervention_name>
    <description>we perform a classic Fast Relaxation Fast Spin Echo (FRFSE) 3D MRI and add compressed sensing&quot; sequence</description>
    <arm_group_label>&quot;CS plus FRFSE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age&gt; 18&#xD;
&#xD;
          -  french understanding and speaking patient&#xD;
&#xD;
          -  Pancreatic MRI prescription for bilio-pancreatic pathology&#xD;
&#xD;
          -  Patient with medical insurance&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  previous biliary surgery&#xD;
&#xD;
          -  MRI contraindication&#xD;
&#xD;
          -  Gadolinium recently injected (48 hours)&#xD;
&#xD;
          -  Patient couldn't stay on apnea 20 seconds&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ZINS Marc, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>GHPSJ</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Groupe Hospitalier Paris Saint Joseph</name>
      <address>
        <city>Paris</city>
        <state>Ile-de-France</state>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>May 11, 2018</study_first_submitted>
  <study_first_submitted_qc>May 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 23, 2018</study_first_posted>
  <last_update_submitted>August 27, 2021</last_update_submitted>
  <last_update_submitted_qc>August 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

